← ANALYSTS · TIPRANKS

Gary Nachman · Canaccord Genuity

#7384among 12,504 TipRanks analysts★★★★★★★★★★
Hits 47% 188 of 401 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +0.3% Over a year after the rating, TipRanks’ measure
Our companies rated now 10 Buy / hold / sell: 7 / 3 / 0
Upside of the analyst’s targets +46.5% Average over 9 current targets, to the last price
The market’s answer to the ratings +1.7% Day-0 move against SPY in the rating’s direction, average over 2 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 14on TipRanks Oct 15 07:30 ETONIWMEton Pharmaceuticals · $1.5B Reiterated Buy $60.00 → $68.00+13.3% +35.2% +0.2%next day −3.2%
Sep 28on TipRanks Sep 29 07:35 ABBVSPYAbbVie · $501B Reiterated Buy $290 +1.6% +1.5%next day −0.9% · 5 days −1.4%
Sep 24on TipRanks Sep 23 07:15 IONSIonis Pharmaceuticals · $7.0B Reiterated Buy $85.00 +98.0% −3.3%next day −0.2% · 5 days +2.3%
Sep 23on TipRanks 07:15 AMGNQQQSPYAmgen · $235B Reiterated Hold $384 −11.2% −0.3%next day +0.1% · 5 days +4.5%
Aug 31on TipRanks Sep 1 08:35 JAZZJazz Pharmaceuticals · $13.9B Reiterated Buy $300 +42.7% +2.8%next day −2.1% · 5 days −4.1%
Aug 12on TipRanks Aug 13 08:40 SRRKIWMScholar Rock Holding · $4.9B Reiterated Buy $62.00 +55.4% +3.1%next day −2.1% · 5 days +5.4%
Aug 12on TipRanks 07:15 ACHVIWMAchieve Life Sciences · $717M Reiterated Buy $13.00 +103.8% −1.4%next day +7.7% · 5 days +27.9%
Aug 10on TipRanks 07:07 ANIPIWMANI Pharmaceuticals · $1.7B Reiterated Hold $91.00 → $90.00−1.1% +24.5% −3.2%next day −1.3% · 5 days +0.4%
Aug 6on TipRanks 07:06 ADMAIWMADMA Biologics · $2.4B Reiterated Buy $18.00 +68.5% +8.8%next day −2.2% · 5 days −7.7%
Oct 6on TipRanks 07:50 PCRXIWMPacira Pharmaceuticals · $1.4B Reiterated Hold — — −4.3%next day −0.7% · 5 days −5.5%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗